Stroke. Cerebellar stroke syndrome
Conditions
Interventions
Intervention 1: Intervention group: Standard treatment included pregabalin tablets 50 to 75 mg twice daily and duloxetine tablets 20 mg twice daily for 3 months plus 3% silymarin topical gel on the sh
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Age 18 to 75 years Stroke Shoulder and scapula muscle pain and stiffness
Exclusion criteria
Exclusion criteria: Pregnancy or breastfeeding Kidney or liver failure Use of painkillers Substance abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean pain score. Timepoint: Before intervention and 3 months later. Method of measurement: Using Visual Analog Scale (VAS).;Degree and frequency of muscle cramps. Timepoint: Before intervention and 3 months later. Method of measurement: Using clinical examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Local complications (redness, burning, itching). Timepoint: 3 months after intervention. Method of measurement: By taking history.;Mean quality of life score. Timepoint: Before intervention and 3 months later. Method of measurement: Using World Health Organization Quality of Life Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyedeh Zahra Mousavi Golbar
Hamedan University of Medical Sciences
Outcome results
None listed